Market closed

ICON plc/$ICLR

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Ticker

$ICLR

Sector

Health Care

Trading on

NASDAQ

Industry

Life Sciences Tools & Services

Headquarters

Dublin, Ireland

Employees

42,250

Website

www.iconplc.com

ICON plc Metrics

BasicAdvanced

$18B

24.25 $8.99

1.25 -

Price and volume

Market cap

$18B

Beta

1.25

52-week high

$347.72

52-week low

$183.38

Average daily volume

892K

Financial strength

Current ratio

1.341

Quick ratio

1.291

Long term debt to equity

36.299

Total debt to equity

36.604

Interest coverage (TTM)

4.29%

Management effectiveness

Return on assets (TTM)

4.17%

Return on equity (TTM)

7.98%

Valuation

Price to earnings (TTM)

24.254

Price to revenue (TTM)

2.169

Price to book

1.84

Price to tangible book (TTM)

-6.17

Price to free cash flow (TTM)

14.658

Growth

Revenue change (TTM)

3.63%

Earnings per share change (TTM)

44.69%

3-year revenue growth (CAGR)

24.01%

3-year earnings per share growth (CAGR)

45.15%

What the Analysts think about ICON plc

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for ICON plc stock.

ICON plc Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

ICON plc Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

ICON plc News

AllArticlesVideos

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Icon Public Limited Company - ICLR

Accesswire·4 days ago

ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Business Wire·1 week ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Icon Public Limited Company - ICLR

Accesswire·2 weeks ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ICLR

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ICON plc stock?

ICON plc (ICLR) has a market cap of $18B as of January 15, 2025.

What is the P/E ratio for ICON plc stock?

The price to earnings (P/E) ratio for ICON plc (ICLR) stock is 24.25 as of January 15, 2025.

Does ICON plc stock pay dividends?

No, ICON plc (ICLR) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next ICON plc dividend payment date?

ICON plc (ICLR) stock does not pay dividends to its shareholders.

What is the beta indicator for ICON plc?

ICON plc (ICLR) has a beta rating of 1.25. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.